REQUIRES LOGIN
Email a friend about this page:
This section provides links to some of the recent and archived reports, studies and research that are important to managed care pharmacy.
Medicare Payment Advisory Commission (MedPAC): Status report on Part D, with focus on beneficiaries with high drug spending (March 2012)
United States Government Accountability Office Testimony on Drug Shortages: FDA's Ability to Respond Should Be Strengthened (December 2011)
HHS Office of Inspector General: Comparison of Average Sales Prices and Average Manufacturer Prices: An Overview of 2010 (November 2011)
Pharmaceutical Care Management Association (PCMA): How Copay Coupons Could Raise Prescription Drug Costs By $32 Billion Over the Next Decade (November 2011)
HHS Office of Inspector General: Concerns with Rebates in the Medicare Part D Program (March 2011)
HHS Office of Inspector General Audit Report on Illegal CMS Payments for Medicare part D (August 2010)
HHS Brief Examines Factors Affecting Generic Use and Cost Savings (December 2010)
HHS Study Finds up to 129 Million People Could Be Denied Affordable Coverage without Health Reform (January 2011)
HHS Office of Inspector General: Review of Erectile Dysfunction Drugs in the Medicare Part D Program
National Pharmaceutical Council: Comparative Effectiveness Research: Do Employers Care? What Will They Do? (June 2011)
HHS Office of Inspector General: Review of Medicare Part B Avastin and Lucentis Treatments for Age-Related Macular Degeneration (September 2011)
PharmMD 2011 MTM Industry Trend Report (September 2011)
HHS Office of Inspector General: Review of Drug Costs to Medicaid Pharmacies and Thier Relation to Benchmark Prices (October 2011)